林岩松. The clinical significance of thyroglobulin antibody measurement in 131I therapy of differentiated thyroid carcinoma[J]. China Oncology, 2019, 29(6): 452-456.
林岩松. The clinical significance of thyroglobulin antibody measurement in 131I therapy of differentiated thyroid carcinoma[J]. China Oncology, 2019, 29(6): 452-456. DOI: 10.19401/j.cnki.1007-3639.2019.06.009.
The clinical significance of thyroglobulin antibody measurement in 131I therapy of differentiated thyroid carcinoma
Serum thyroglobulin (Tg) is a major tumor marker for follow-up after treatment of patients with differentiated thyroid carcinoma (DTC). However
the accuracy of Tg measurement is interfered by thyroglobulin antibody (TgAb)
limiting the predictive value of Tg. Therefore
the follow-up of DTCs with positive TgAb remains a clinical puzzlement. Some researchers have proposed that TgAb could also serve as a surrogate tumor marker for the monitoring of DTC
but it remains controversial over the relationship between TgAb and disease status or prognosis after treatment. This article reviewed the clinical significance of TgAb measurement i
n
131
I therapy of DTC
in order to provide more evidence for clinical decision making in patients with positive TgAb.
The interpretation of management guidelines for children with thyroid nodules and differentiated thyroid cancer: radioactive iodine therapy and new progress
Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: progress in external beam radiotherapy (EBRT) for differentiated thyroid cancer
Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: progress in ultrasound, CT, MRI and ablation of thyroid nodules and differentiated thyroid cancer
Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: progress in nuclear medicine diagnosis and treatment of differentiated thyroid cancer
Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: precision treatment guided by genotyping
Related Author
杨 珂
郑 容
Xiaoliang LIU
Xiaorong HOU
Ruyu LIU
Chenyi WANG
Bo ZHANG
Yansong LIN
Related Institution
中国医学科学院肿瘤医院核医学科
Department of Radiation Oncology, Peking Union Medical College Hospital & Chinese Academy of Medical Sciences
Japan Friendship Hospital (Institute of Clinical Medical Sciences), Peking Union Medical College, Chinese Academy of Medical Sciences,, China
Department of Ultrasound, China-Japan Friendship Hospital
National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Center of Respiratory Medicine, China-Japan Friendship Hospital